Chondroitin Sulfate Proteoglycans
"Chondroitin Sulfate Proteoglycans" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteoglycans consisting of proteins linked to one or more CHONDROITIN SULFATE-containing oligosaccharide chains.
| Descriptor ID |
D011508
|
| MeSH Number(s) |
D09.698.735.200 D12.776.395.650.750
|
| Concept/Terms |
Chondroitin Sulfate Proteoglycans- Chondroitin Sulfate Proteoglycans
- Proteoglycans, Chondroitin Sulfate
- Sulfate Proteoglycans, Chondroitin
- Proteochondroitin Sulfate
- Proteochondroitin Sulfates
- Chondroitin Sulfate Proteoglycan
- Proteoglycan, Chondroitin Sulfate
- Sulfate Proteoglycan, Chondroitin
|
Below are MeSH descriptors whose meaning is more general than "Chondroitin Sulfate Proteoglycans".
Below are MeSH descriptors whose meaning is more specific than "Chondroitin Sulfate Proteoglycans".
This graph shows the total number of publications written about "Chondroitin Sulfate Proteoglycans" by people in this website by year, and whether "Chondroitin Sulfate Proteoglycans" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2001 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 1 | 3 |
| 2019 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chondroitin Sulfate Proteoglycans" by people in Profiles.
-
Cohesin haploinsufficiency is tolerated in Cbfb::MYH11-driven murine acute myeloid leukemia. Exp Hematol. 2026 Jan; 153:105287.
-
Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-? signalling. Br J Dermatol. 2024 12 23; 192(1):104-117.
-
Proteomic profile of melanoma cell-derived small extracellular vesicles in patients' plasma: a potential correlate of melanoma progression. J Extracell Vesicles. 2021 02; 10(4):e12063.
-
Cornelia de Lange syndrome in diverse populations. Am J Med Genet A. 2019 02; 179(2):150-158.
-
De novo heterozygous mutations in SMC3 cause a range of Cornelia de Lange syndrome-overlapping phenotypes. Hum Mutat. 2015 Apr; 36(4):454-62.
-
Enrichment of committed human nucleus pulposus cells expressing chondroitin sulfate proteoglycans under alginate encapsulation. Osteoarthritis Cartilage. 2015 Jul; 23(7):1194-203.
-
Global transcriptional disturbances underlie Cornelia de Lange syndrome and related phenotypes. J Clin Invest. 2015 Feb; 125(2):636-51.
-
Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery. Clin Cancer Res. 2014 Dec 15; 20(24):6529-40.
-
T lymphocytes redirected against the chondroitin sulfate proteoglycan-4 control the growth of multiple solid tumors both in vitro and in vivo. Clin Cancer Res. 2014 Feb 15; 20(4):962-71.
-
Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study. J Proteome Res. 2012 Mar 02; 11(3):1937-48.